Catalyst Biosciences CEO Nassim Usman's 2019 pay falls 51% to $1.2M

Catalyst Biosciences reports 2019 executive compensation

By ExecPay News

Published: May 1, 2020

Catalyst Biosciences reported fiscal year 2019 executive compensation information on May 1, 2020.
In 2019, three executives at Catalyst Biosciences received on average a compensation package of $801K, a 48% decrease compared to previous year.
Average pay of disclosed executives at Catalyst Biosciences
Nassim Usman, Chief Executive Officer, received $1.2M in total, which decreased by 51% compared to 2018. 44% of Usman's compensation, or $525K, was in salary. Usman also received $212K in non-equity incentive plan, $455K in option awards, as well as $7.1K in other compensation.
Howard Levy, Chief Medical Officer, received a compensation package of $733K, which decreased by 39% compared to previous year. 57% of the compensation package, or $420K, was in salary.
Fletcher Payne, Chief Financial Officer, earned $471K in 2019, a 51% decrease compared to previous year.

Related executives

Nassim Usman

Catalyst Biosciences

Chief Executive Officer

Fletcher Payne

Catalyst Biosciences

Chief Financial Officer

Howard Levy

Catalyst Biosciences

Chief Medical Officer

You may also like

Source: SEC filing on May 1, 2020.